The effect of oral prednisolone on visual evoked potential latencies in acute optic neuritis monitored in a prospective, randomized, controlled study

Documenta Ophthalmologica: The Journal of Clinical Electrophysiology and Vision - The Official Journal of the International Society for Clinical Electrophysiology and Vision

Volumn 91, Issue 2, 1995, Pages 165-179

  Trauzettel Klosinski, Susanne ^a   Diener, Hans Christoph ^b   Dietz, Klaus ^c   Zrenner, Eberhart ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Latencies; Optic neuritis; Oral methylprednisolone; Visual evoked potentials

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE; THIAMINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EVOKED VISUAL RESPONSE; HUMAN; OPTIC NERVE DISEASE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0029550412     PISSN: 00124486     EISSN: 15732622     Source Type: Journal    
DOI: 10.1007/BF01203696     Document Type: Article

References (37)

1. A trial of corticotrophin gelatin injection in acute optic neuritis
2. Treatment of optic neuritis by retrobulbar injection of triamcinolone
3. Treatment of acute retrobulbar neuritis with corticotrophin
4. Der Flimmertest: Ein neues, einfaches Verfahren zur Diagnostik der Neuritis nervi optici
5. Various stages of optic neuritis assessed by subjective brightness of flicker
6. Measurement of brightness sensation caused by flickering light: a simple and highly specific test for assessing the florid stage of optic neuritis
7. The Tübingen Study on optic neuritis treatment: a prospective, randomized and controlled trial
8. The Aulhorn flicker test: possibilities and limits: its use in optic neuritis for diagnosis, differential diagnosis, monitoring the course of the disease and assessing the effect of oral prednisolone
9. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis
10. Optic neuritis treatment trial: one-year follow-up results
11. The pattern visual evoked potential: a multicenter study using standardized techniques
12. The effect of prednisolone on acute optic neuritis: a double-blind study
13. Der Einfluss von Prednisolon auf den Verlauf der Neuritis nervi optici: Ergebnisse einer Doppelblindstudie
14. Visuell evozierte Potentiale: methodische Probleme-Variation der Reizparameter
15. Acute optic neuritis: its clinical features and their relation to prognosis for recovery of vision
16. Optic neuritis: a prospective study
17. Later course and prognosis of optic neuritis
18. Shortterm neurophysiological monitoring in multiple sclerosis bouts: evaluation of steroid treatment
19. Evoked potentials in multiple sclerosis before and after highdose methylprednisolone infusion
20. A comparison of the flush and pattern-evoked potential in unilateral optic neuritis
21. The dissociation of amplitude and latency changes in the pattern-evoked response following optic neuritis
22. Visuell evozierte Potentiale
23. Visual evoked responses in the diagnosis and management of patients suspected of multiple sclerosis
24. Pathophysiology of demyelinating disease
25. Visual evoked potentials after optic neuritis: effect of time interval, age and disease dissemination
26. Serial recordings of visual and somatosensory evoked potentials in multiple sclerosis
27. Vergleich des Flimmertests nach Aulhorn mit den visuell evozierten Potentialen in der Diagnostik der Neuritis nervi optici
28. Delayed pattern evoked responses in optic neuritis in relation to visual acuity
29. Die Bedeutung der visuell evozierten Potentiale für die Differentialdiagnose neurologischer Erkrankungen
30. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis
31. Managing optic neuritis: results of the optic neuritis treatment trial
32. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis, II: MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial
33. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis, I: clinical results of a multicenter, randomized, double-blind placebo-controlled trial